Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8NHG8

Entry ID Method Resolution Chain Position Source
AF-Q8NHG8-F1 Predicted AlphaFoldDB

183 variants for Q8NHG8

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1221536508
CA367245261
2 G>C No ClinGen
TOPMed
CA367245274
rs1347821428
3 A>T No ClinGen
gnomAD
CA367245322
rs1239768249
4 K>Q No ClinGen
gnomAD
CA367245337
rs1262391942
5 Q>E No ClinGen
gnomAD
rs1303274563
CA367245361
7 G>C No ClinGen
TOPMed
gnomAD
rs1303274563
CA367245360
7 G>R No ClinGen
TOPMed
gnomAD
rs1303274563
CA367245359
7 G>S No ClinGen
TOPMed
gnomAD
CA367245364
rs1339711874
7 G>V No ClinGen
TOPMed
gnomAD
rs761956095
CA4204248
8 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs952268581
CA156592049
8 P>L No ClinGen
TOPMed
gnomAD
CA367245401
rs1227590084
10 A>V No ClinGen
gnomAD
rs1398971025
CA367245405
11 A>V No ClinGen
TOPMed
CA367245414
rs1269720585
12 N>K No ClinGen
TOPMed
gnomAD
rs1224760969
CA367245412
12 N>S No ClinGen
TOPMed
gnomAD
rs1488218643
CA367245419
13 G>D No ClinGen
gnomAD
rs1192135641
CA367245426
14 R>L No ClinGen
gnomAD
CA367245422
rs1201784771
14 R>S No ClinGen
TOPMed
gnomAD
CA367245433
rs1475940580
15 T>M No ClinGen
TOPMed
gnomAD
CA4204250
rs750693861
16 R>H No ClinGen
ExAC
gnomAD
TCGA novel 16 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1411141608
CA367245442
17 A>E No ClinGen
TOPMed
gnomAD
rs1411141608
CA367245443
17 A>G No ClinGen
TOPMed
gnomAD
rs1411141608
CA367245444
17 A>V No ClinGen
TOPMed
gnomAD
CA367245458
rs1163616735
19 S>L No ClinGen
gnomAD
rs1273268126
CA367245461
20 G>C No ClinGen
TOPMed
rs1332143328
CA367245468
21 S>L No ClinGen
TOPMed
rs991752819
CA156592052
22 D>E No ClinGen
TOPMed
CA367245475
rs1162382138
22 D>G No ClinGen
gnomAD
CA156592053
rs913585707
24 P>S No ClinGen
TOPMed
gnomAD
CA156592054
rs945106276
25 S>F No ClinGen
TOPMed
gnomAD
CA367245489
rs1327003842
25 S>P No ClinGen
gnomAD
CA367245498
rs1446972989
26 S>N No ClinGen
gnomAD
CA367245504
rs1282240144
27 S>N No ClinGen
TOPMed
gnomAD
CA367245510
rs1429196772
28 S>G No ClinGen
TOPMed
CA367245516
rs1352186120
28 S>R No ClinGen
TOPMed
TCGA novel 29 G>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA367245532
rs1395560838
31 A>D No ClinGen
TOPMed
gnomAD
rs780405670
CA4204252
32 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA4204253
rs753728684
33 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA367245556
rs1214623819
35 A>E No ClinGen
gnomAD
rs1214623819
CA367245558
35 A>V No ClinGen
gnomAD
rs1308820217
CA367245565
37 G>S No ClinGen
gnomAD
CA156592056
rs932535983
40 G>D No ClinGen
TOPMed
CA367245593
rs1187232561
41 A>G No ClinGen
TOPMed
gnomAD
CA367245589
rs1380538610
41 A>S No ClinGen
gnomAD
CA156592057
rs1050106525
42 R>W No ClinGen
TOPMed
TCGA novel 43 A>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA367245622
rs1236109641
47 G>W No ClinGen
TOPMed
gnomAD
rs1227671330
CA367245631
48 R>T No ClinGen
TOPMed
CA367245639
rs1360237580
49 F>S No ClinGen
TOPMed
gnomAD
CA156592058
rs962023236
49 F>V No ClinGen
TOPMed
CA367245653
rs1213237700
51 A>V No ClinGen
TOPMed
rs1370286948
CA367245657
52 Q>P No ClinGen
TOPMed
CA367245680
rs1333493051
55 S>R No ClinGen
TOPMed
CA367245687
rs1462684963
56 A>V No ClinGen
TOPMed
CA367245695
rs1249803865
57 H>Q No ClinGen
gnomAD
CA367245701
rs1372785071
58 Q>L No ClinGen
TOPMed
rs1434693833
CA367245708
59 P>R No ClinGen
TOPMed
CA156592061
rs557498081
60 S>G No ClinGen
1000Genomes
TOPMed
gnomAD
CA367245732
rs1480098921
63 G>D No ClinGen
TOPMed
rs536666116
CA4204254
64 G>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1392053724
CA367245747
66 A>P No ClinGen
TOPMed
rs1375810810
CA367245758
68 A>T No ClinGen
TOPMed
rs1159833655
CA367245765
69 A>P No ClinGen
gnomAD
rs1418003829
CA367245769
69 A>V No ClinGen
TOPMed
CA367245786
rs1210693413
72 P>R No ClinGen
TOPMed
CA367245784
rs1281490797
72 P>S No ClinGen
TOPMed
rs1385392217
CA367245789
73 A>P No ClinGen
TOPMed
gnomAD
CA367245788
rs1385392217
73 A>S No ClinGen
TOPMed
gnomAD
CA367245790
rs1385392217
73 A>T No ClinGen
TOPMed
gnomAD
CA367245793
rs1445891464
73 A>V No ClinGen
TOPMed
gnomAD
CA367245795
rs1312029847
74 A>P No ClinGen
TOPMed
CA367245794
rs1312029847
74 A>T No ClinGen
TOPMed
rs1372172775
CA367245798
74 A>V No ClinGen
TOPMed
gnomAD
rs1583559001
CA367245806
76 A>T No ClinGen
Ensembl
CA156592070
rs913553039
78 P>A No ClinGen
TOPMed
rs1299669432
CA367245826
79 R>P No ClinGen
TOPMed
gnomAD
CA367245837
rs1166377589
81 R>S No ClinGen
TOPMed
CA367245847
rs1475324365
82 S>F No ClinGen
TOPMed
CA367245851
rs1256386645
83 L>V No ClinGen
TOPMed
CA367245863
rs1264419941
85 G>W No ClinGen
TOPMed
CA4204255
rs184594665
87 V>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs931332579
CA156592073
89 S>G No ClinGen
TOPMed
CA156592075
rs925095983
94 A>S No ClinGen
TOPMed
gnomAD
CA156592074
rs925095983
94 A>T No ClinGen
TOPMed
gnomAD
rs1049546256
CA367245928
96 A>E No ClinGen
TOPMed
gnomAD
CA156592076
rs1049546256
96 A>G No ClinGen
TOPMed
gnomAD
CA367245929
rs1049546256
96 A>V No ClinGen
TOPMed
gnomAD
CA367245939
rs1315982767
98 Q>R No ClinGen
gnomAD
CA367245948
rs1412653577
99 S>F No ClinGen
TOPMed
CA156592077
rs912396825
100 P>A No ClinGen
TOPMed
CA367245951
rs912396825
100 P>S No ClinGen
TOPMed
rs1281380957
CA367245961
101 F>L No ClinGen
TOPMed
gnomAD
rs1200398311
CA367245979
104 P>A No ClinGen
gnomAD
rs1200398311
CA367245980
104 P>S No ClinGen
gnomAD
rs1166397645
CA367245991
105 N>K No ClinGen
TOPMed
TCGA novel 105 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1462922885
CA367246019
109 G>D No ClinGen
gnomAD
rs1461514467
CA367246016
109 G>S No ClinGen
TOPMed
rs777225411
CA4204258
110 P>Q No ClinGen
ExAC
TOPMed
gnomAD
rs777225411
CA367246026
110 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA367246023
rs1583559075
110 P>S No ClinGen
Ensembl
rs897814682
CA156592079
112 G>R No ClinGen
TOPMed
gnomAD
rs897814682
CA367246035
112 G>S No ClinGen
TOPMed
gnomAD
CA367246073
rs1468987960
117 V>G No ClinGen
TOPMed
rs1215564193
CA367246069
117 V>L No ClinGen
TOPMed
rs1272727353
CA367246095
120 S>I No ClinGen
TOPMed
rs1170740940
CA367246100
121 P>S No ClinGen
gnomAD
CA156592081
rs1049606979
123 D>E No ClinGen
TOPMed
gnomAD
rs1270537197
CA367246116
123 D>G No ClinGen
TOPMed
CA367246124
rs1470108774
124 G>V No ClinGen
gnomAD
rs776251695
CA4204262
126 G>S No ClinGen
ExAC
gnomAD
CA367246135
rs1399785257
126 G>V No ClinGen
gnomAD
rs1203633005
CA367246136
127 G>S No ClinGen
TOPMed
gnomAD
rs763439410
CA4204263
129 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1330913241
CA367246148
129 D>H No ClinGen
gnomAD
rs768835266
CA4204264
130 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs774932282
CA4204265
131 P>A No ClinGen
ExAC
TOPMed
CA156592082
rs927409888
132 V>G No ClinGen
Ensembl
rs1326330641
CA367246175
CA367246174
134 G>R No ClinGen
TOPMed
gnomAD
CA367246176
rs1326330641
134 G>W No ClinGen
TOPMed
gnomAD
CA156592083
rs937468746
135 S>G No ClinGen
Ensembl
rs767733858
CA4204267
135 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs750567165
CA4204268
136 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs1250881912
CA367246194
137 G>D No ClinGen
gnomAD
CA367246192
rs1197184095
137 G>R No ClinGen
gnomAD
rs1196197106
CA367246201
138 G>V No ClinGen
gnomAD
rs1033830989
CA367246207
139 P>L No ClinGen
TOPMed
gnomAD
rs1033830989
CA156592085
139 P>Q No ClinGen
TOPMed
gnomAD
rs760828374
CA4204269
140 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs766778624
CA367246219
142 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs766778624
CA4204270
142 V>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 144 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA367246231
rs1194975102
144 G>R No ClinGen
TOPMed
rs754819476
CA4204272
146 L>S No ClinGen
ExAC
TOPMed
gnomAD
rs541343305
CA367246257
148 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs541343305
CA4204273
148 A>V No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4204276
rs758372967
149 H>Q No ClinGen
ExAC
gnomAD
CA4204274
rs752713010
149 H>Y No ClinGen
ExAC
gnomAD
CA4204277
rs746578454
150 L>F No ClinGen
ExAC
gnomAD
CA367246285
rs966347232
153 H>P No ClinGen
TOPMed
CA4204281
rs745452890
153 H>Q No ClinGen
ExAC
TOPMed
gnomAD
CA156592087
rs966347232
153 H>R No ClinGen
TOPMed
rs774537833
CA4204282
154 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs772751188
CA4204284
154 M>R No ClinGen
ExAC
gnomAD
CA4204283
rs774537833
154 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA156592088
rs1032432013
155 F>L No ClinGen
TOPMed
gnomAD
CA4204379
rs147318339
165 K>E No ClinGen
ESP
ExAC
gnomAD
rs1239798095
CA367249087
166 F>L No ClinGen
TOPMed
CA4204380
rs756452477
167 V>I No ClinGen
ExAC
gnomAD
CA367249133
rs1345556040
173 D>G No ClinGen
gnomAD
CA156596520
rs868553154
174 L>S No ClinGen
Ensembl
CA367249169
rs1363725715
178 M>I No ClinGen
gnomAD
CA4204381
rs140727226
178 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs979815730
CA156596521
178 M>V No ClinGen
Ensembl
rs1424332478
CA367249215
184 R>* No ClinGen
gnomAD
CA4204383
rs142290977
184 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1350517194
CA367249245
186 T>I No ClinGen
gnomAD
CA367245090
rs1435544394
189 E>A No ClinGen
gnomAD
TCGA novel 191 V>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA156600130
rs749781284
191 V>I No ClinGen
Ensembl
TCGA novel 194 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs550905339
CA4204402
195 D>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs758403495
CA4204403
199 C>Y No ClinGen
ExAC
gnomAD
rs1470187292
CA367245163
200 A>T No ClinGen
gnomAD
rs751775912
CA4204405
202 C>W No ClinGen
ExAC
gnomAD
CA156600132
rs866147007
204 E>D No ClinGen
Ensembl
rs745627656
CA4204408
208 Q>E No ClinGen
ExAC
gnomAD
rs181107014
CA367245224
208 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1331015548
CA367245222
208 Q>R No ClinGen
gnomAD
rs779838395
CA4204410
210 D>Y No ClinGen
ExAC
gnomAD
CA367245251
rs1282002657
212 I>L No ClinGen
gnomAD
rs748891643
CA4204411
213 A>V No ClinGen
ExAC
gnomAD
CA4204412
rs767981100
214 R>* No ClinGen
ExAC
gnomAD
CA4204414
rs761417571
220 I>M No ClinGen
ExAC
gnomAD
CA367245315
rs1291550203
220 I>V No ClinGen
gnomAD
CA367245351
rs1583596949
222 H>L No ClinGen
Ensembl
CA367245346
rs1490147486
222 H>Y No ClinGen
gnomAD
CA367246341
rs1391067439
227 D>G No ClinGen
gnomAD
CA156600938
rs868322083
234 R>K No ClinGen
gnomAD
CA367246394
rs868322083
234 R>T No ClinGen
gnomAD
rs747638902
CA156600940
238 E>D No ClinGen
ExAC
TOPMed
gnomAD
CA4204434
rs771774085
242 D>V No ClinGen
ExAC

No associated diseases with Q8NHG8

1 regional properties for Q8NHG8

Type Name Position InterPro Accession
domain Zinc finger, RING-type 198 - 239 IPR001841

Functions

Description
EC Number 2.3.2.27 Aminoacyltransferases
Subcellular Localization
  • Endosome membrane ; Peripheral membrane protein
  • Lysosome membrane ; Peripheral membrane protein
  • Presynaptic cell membrane ; Peripheral membrane protein
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

14 GO annotations of cellular component

Name Definition
anchoring junction A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix.
cell projection A prolongation or process extending from a cell, e.g. a flagellum or axon.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytoplasmic vesicle membrane The lipid bilayer surrounding a cytoplasmic vesicle.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
endosome membrane The lipid bilayer surrounding an endosome.
fibrillar center A structure found most metazoan nucleoli, but not usually found in lower eukaryotes; surrounded by the dense fibrillar component; the zone of transcription from multiple copies of the pre-rRNA genes is in the border region between these two structures.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
lysosomal membrane The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
presynaptic membrane A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.

2 GO annotations of molecular function

Name Definition
metal ion binding Binding to a metal ion.
ubiquitin protein ligase activity Catalysis of the transfer of ubiquitin to a substrate protein via the reaction X-ubiquitin + S -> X + S-ubiquitin, where X is either an E2 or E3 enzyme, the X-ubiquitin linkage is a thioester bond, and the S-ubiquitin linkage is an amide bond: an isopeptide bond between the C-terminal glycine of ubiquitin and the epsilon-amino group of lysine residues in the substrate or, in the linear extension of ubiquitin chains, a peptide bond the between the C-terminal glycine and N-terminal methionine of ubiquitin residues.

2 GO annotations of biological process

Name Definition
proteasome-mediated ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome.
protein K48-linked ubiquitination A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q71FD5 Znrf2 E3 ubiquitin-protein ligase ZNRF2 Mus musculus (Mouse) PR
10 20 30 40 50 60
MGAKQSGPAA ANGRTRAYSG SDLPSSSSGG ANGTAGGGGG ARAAAAGRFP AQVPSAHQPS
70 80 90 100 110 120
ASGGAAAAAA APAAPAAPRS RSLGGAVGSV ASGARAAQSP FSIPNSSSGP YGSQDSVHSS
130 140 150 160 170 180
PEDGGGGRDR PVGGSPGGPR LVIGSLPAHL SPHMFGGFKC PVCSKFVSSD EMDLHLVMCL
190 200 210 220 230 240
TKPRITYNED VLSKDAGECA ICLEELQQGD TIARLPCLCI YHKGCIDEWF EVNRSCPEHP
SD